3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Ovarian Neoplasms
24
Uterine Cervical Neoplasms
18
Fallopian Tube Neoplasms
15
Endometrial Neoplasms
13
Neoplasm Metastasis
9
Breast Neoplasms
9
Pancreatic Neoplasms
8
Uterine Cervical Dysplasia
6
Melanoma
6
Colorectal Neoplasms
6
Prostatic Neoplasms
5
Stomach Neoplasms
4
Precancerous Conditions
4
Carcinosarcoma
4
Carcinoma, Renal Cell
4
Vulvar Neoplasms
3
Uterine Neoplasms
3
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Squamous Intraepithelial Lesions
3
Sarcoma
3
Salivary Gland Neoplasms
3
Neoplasms
3
Carcinoma, Ovarian Epithelial
3
Carcinoma, Non-Small-Cell Lung
3
Anus Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Skin Neoplasms
2
Rectal Neoplasms
2
Papillomavirus Infections
2
Interventions
pembrolizumab
3
Paclitaxel
3
Carboplatin
3
niraparib
2
anlotinib
2
Pemetrexed
2
Palliative Care
2
Interviews as Topic
2
Gemcitabine
2
Educational Status
2
Bevacizumab
2
temsirolimus
1
relacorilant
1
olaparib
1
nilotinib
1
liposomal doxorubicin
1
lenvatinib
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Topotecan
1
Therapeutic Touch
1
Radiotherapy
1
Pregnancy Tests
1
Ocoxin
1
Nivolumab
1
Methods
1
Laparoscopy
1
Human Papillomavirus DNA Tests
1
Fulvestrant
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Genital Neoplasms, Female
×
Biopsy
×
Gynecologic
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled